These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7895425

  • 21. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.
    McGuirk JP, Seropian S, Howe G, Smith B, Stoddart L, Cooper DL.
    Bone Marrow Transplant; 1999 Dec; 24(11):1253-8. PubMed ID: 10642818
    [Abstract] [Full Text] [Related]

  • 22. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.
    Durandy A, Brousse N, Rozenberg F, De Saint Basile G, Fischer AM, Fischer A.
    J Clin Invest; 1992 Sep; 90(3):945-52. PubMed ID: 1326002
    [Abstract] [Full Text] [Related]

  • 23. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
    Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 02; 88(44):3123-6. PubMed ID: 19159594
    [Abstract] [Full Text] [Related]

  • 24. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 02; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R, Carbone R, Reiss M, Lacy J.
    Clin Cancer Res; 2003 May 02; 9(5):1931-9. PubMed ID: 12738752
    [Abstract] [Full Text] [Related]

  • 27. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E, van der Bij W, de Boer W, Timens W, Middeldorp J, The TH.
    J Med Virol; 2003 Feb 02; 69(2):258-66. PubMed ID: 12683416
    [Abstract] [Full Text] [Related]

  • 28. Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation.
    Gruhn B, Meerbach A, Häfer R, Zell R, Wutzler P, Zintl F.
    Bone Marrow Transplant; 2003 Jun 02; 31(11):1023-5. PubMed ID: 12774054
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA.
    Am J Clin Pathol; 2005 Feb 02; 123(2):222-8. PubMed ID: 15842046
    [Abstract] [Full Text] [Related]

  • 31. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI.
    Semin Hematol; 2003 Apr 02; 40(2):116-23. PubMed ID: 12704588
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.
    Benkerrou M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier JL, Le Bidois J, Le Deist F, Blanche S, Fischer A.
    Blood; 1998 Nov 01; 92(9):3137-47. PubMed ID: 9787149
    [Abstract] [Full Text] [Related]

  • 35. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE, Lorber KM, Marcarelli M, Bia MJ, Kliger AS, Lorber MI.
    Transplant Proc; 1995 Feb 01; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rapid occurrence of lymphoproliferative disease after pancreas-kidney transplantation performed during acute primary Epstein-Barr virus infection.
    Kroes AC, van der Pijl JW, van Tol MJ, van Krieken JH, Falk KI, Gratama JW, van der Woude FJ.
    Clin Infect Dis; 1997 Mar 01; 24(3):339-43. PubMed ID: 9114182
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
    Cohen JI.
    Medicine (Baltimore); 1991 Mar 01; 70(2):137-60. PubMed ID: 1848644
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.